Efficacy of risperidone for the treatment of aggressive children in a private practice setting

The efficacy of risperidone (Risperdal) for the treatment of 3 chronically aggressive children was evaluated using an open-label, multiple-baseline design in a private practice setting. Results of both parent and teacher ratings demonstrated a reduction in aggressive and delinquent behavior in 2 of...

Full description

Bibliographic Details
Main Author: Patterson, Brian Robert
Format: Others
Published: Scholarly Commons 2001
Subjects:
Online Access:https://scholarlycommons.pacific.edu/uop_etds/2694
https://scholarlycommons.pacific.edu/cgi/viewcontent.cgi?article=3693&context=uop_etds
Description
Summary:The efficacy of risperidone (Risperdal) for the treatment of 3 chronically aggressive children was evaluated using an open-label, multiple-baseline design in a private practice setting. Results of both parent and teacher ratings demonstrated a reduction in aggressive and delinquent behavior in 2 of 3 participants upon introduction of Risperdal, with the third responding in similar fashion upon final dose adjustment. Each participant reported no occurrences of side effects. These findings suggest that Risperdal was well tolerated, and may serve as a safe and effective treatment modality for this challenging population.